| BMC Surgery | |
| Comparison of robot-assisted retroperitoneal laparoscopic adrenalectomy versus retroperitoneal laparoscopic adrenalectomy for large pheochromocytoma: a single-centre retrospective study | |
| Sheng-Qiang Fu1  Wen-Jie Xie1  Ji Liu1  Ming Ma1  Xiao-Rong Yang1  Yi-Fu Liu1  Ting Sun1  Bin-Bin Gong1  Chang-Shui Zhuang2  | |
| [1] Department of Urology, the First Affiliated Hospital of Nanchang University, 330000, Nanchang, Jiangxi Province, China;Union Shenzhen Hospital, Huazhong University of Science and Technology, 518052, Shenzhen, China; | |
| 关键词: Pheochromocytoma; Robotic surgery; Laparoscopic adrenalectomy; | |
| DOI : 10.1186/s12893-020-00895-5 | |
| 来源: Springer | |
PDF
|
|
【 摘 要 】
BackgroundTo evaluate the feasibility and safety of robot-assisted retroperitoneal laparoscopic adrenalectomy (RARLA) for large pheochromocytomas (PHEOs; size≥6 cm) compared with retroperitoneal laparoscopic adrenalectomy (RLA).MethodsFifty-one patients who underwent adrenalectomy for large PHEOs between March 2016 and January 2019 were enrolled and divided into two groups, including 32 RLA cases and 19 RARLA cases. We compared the perioperative efficacy and long-term follow-up results between the two groups.ResultsPreoperative data, including demographics, comorbidities and tumour characteristics, were similar between the groups. Intraoperatively, the RARLA group had a lower incidence of haemodynamic instability (26.3% vs. 56.2%, P = 0.038) and less intraoperative blood loss (100 ml vs. Two hundred milliliter, P = 0.042) than the RLA group. The groups showed no significant differences in operative time or transfusion rates. Postoperatively, the time to diet resumption, time to ambulation, time to drainage removal and postoperative hospital stay were shorter in the RARLA group than in the RLA group (1 d vs. 2 d, P = 0.027; 1 d vs. 2 d, P = 0.034; 3 d vs. 5 d, P = 0.002; 5 d vs. 6 d, P = 0.02, respectively). The groups exhibited no significant differences in the duration of anaesthetic use, complications, or long-term follow-up results for the blood pressure (BP) improvement rate.ConclusionsCompared with RLA, RARLA is a safe, feasible and even optimized procedure for large PHEOs.
【 授权许可】
CC BY
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202104268837116ZK.pdf | 3436KB |
PDF